RA Capital Management

Ra Capital Management as of Sept. 30, 2014

Portfolio Holdings for Ra Capital Management

Ra Capital Management holds 43 positions in its portfolio as reported in the September 2014 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
ACADIA Pharmaceuticals (ACAD) 15.4 $131M 5.3M 24.77
Achillion Pharmaceuticals 11.4 $97M 9.7M 9.98
Dyax 9.3 $79M 7.8M 10.12
Sangamo Biosciences (SGMO) 9.2 $78M 7.2M 10.79
BioCryst Pharmaceuticals (BCRX) 8.2 $69M 7.1M 9.78
AVANIR Pharmaceuticals 7.6 $64M 5.4M 11.92
Sunesis Pharmaceuticals 4.1 $35M 4.9M 7.14
Dicerna Pharmaceuticals 3.6 $31M 2.4M 12.73
Bluebird Bio (BLUE) 3.1 $26M 729k 35.88
Ophthotech 2.7 $23M 589k 38.93
Zs Pharma 2.6 $22M 565k 39.23
Tg Therapeutics (TGTX) 2.6 $22M 2.1M 10.67
Novavax 2.5 $21M 5.1M 4.17
Dynavax Technologies Corporation 2.1 $17M 12M 1.43
Versartis 2.0 $17M 899k 18.99
Therapeuticsmd 1.9 $16M 3.5M 4.64
Zafgen 1.7 $14M 733k 19.65
Akebia Therapeutics (AKBA) 1.6 $13M 597k 22.13
Xencor (XNCR) 1.4 $12M 1.2M 9.31
Enanta Pharmaceuticals (ENTA) 1.2 $9.9M 250k 39.57
Tenax Therapeutics 1.1 $9.2M 2.3M 3.93
Scynexis 0.7 $6.2M 840k 7.39
Vical Incorporated 0.7 $6.1M 5.5M 1.12
Auris Med Hldg 0.6 $5.4M 940k 5.77
T2 Biosystems 0.3 $2.5M 138k 18.09
Wafergen Bio-systems 0.3 $2.4M 560k 4.35
Ocera Therapeutics 0.2 $2.0M 418k 4.90
Alimera Sciences 0.2 $1.3M 244k 5.42
Codexis (CDXS) 0.1 $1.2M 504k 2.33
Ptc Therapeutics I (PTCT) 0.1 $1.1M 26k 43.99
Agios Pharmaceuticals (AGIO) 0.1 $1.1M 18k 61.36
Vertex Pharmaceuticals Incorporated (VRTX) 0.1 $1.0M 9.3k 112.26
Merrimack Pharmaceuticals In 0.1 $1.0M 116k 8.78
Repligen Corporation (RGEN) 0.1 $896k 45k 19.91
Keryx Biopharmaceuticals 0.1 $814k 59k 13.75
Regeneron Pharmaceuticals (REGN) 0.1 $883k 2.5k 360.41
Amgen (AMGN) 0.1 $829k 5.9k 140.51
Biogen Idec (BIIB) 0.1 $860k 2.6k 330.77
Celgene Corporation 0.1 $825k 8.7k 94.83
Alkermes (ALKS) 0.1 $823k 19k 42.86
Puma Biotechnology (PBYI) 0.1 $740k 3.1k 238.71
Kythera Biopharmaceuticals I 0.1 $745k 23k 32.75
Newlink Genetics Corporation 0.1 $643k 30k 21.43